Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I hope that everyone is adding shares at the current price.

Anyone who is waiting to add at the 50 or 200 DMA will be sadly disappointed.

Once the public finds out about the huge potential that the company's patented MANF technology offers you'll regret not having bought more shares at the current "bargain basement price."

Ignore anyone that says this is going lower because it isn't. The bottom was yesterday and yesterday's gone.

The "Human Brain Mapping Project" is going to start generating any number of articles related to what companies will benefit from the project. I have to believe that Amarantus will be at the forefront of those discussions especially as it relates to small-cap bio-tech companies.

I think the recent high of .195 will be surpassed within four weeks or sooner.

A joint venture or partnership takes this to over .50 in a day.

GLTA

p.s. Be happy that you found out about the company's tremendous upside before 99.9% of the future shareholders.

Note: Amgen (AMGN) was once a seven cent stock. It's currently trading at $86.82.